Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database

A better understanding of immune-related adverse events is essential for the early detection and appropriate management of these phenomena. We conducted an observational study of cases recorded at the French reference center for hypereosinophilic syndromes and in the French national pharmacovigilanc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Autores principales: Scanvion, Quentin, Béné, Johana, Gautier, Sophie, Grandvuillemin, Aurélie, Le Beller, Christine, Chenaf, Chouki, Etienne, Nicolas, Brousseau, Solenn, Cortot, Alexis B., Mortier, Laurent, Staumont-Sallé, Delphine, Morschhauser, Franck, Forestier, Alexandra, Groh, Matthieu, Launay, David, Hachulla, Eric, Labalette, Myriam, Kahn, Jean-Emmanuel, Lefèvre, Guillaume
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2020
Materias:
Brief Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7153834/
https://ncbi.nlm.nih.gov/pubmed/32313716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1722022
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares